OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 26, 2018
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
March 22, 2018
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
March 20, 2018
An expanded pharma services supply chain facility in Germany boosts Thermo Fisher’s Pharma Services footprint in Europe.
March 19, 2018
Hovione plans to continue to expand its sites in Portugal and Ireland for chemical synthesis, spray drying, and laboratory analysis.
The CDMO’s new blow-fill-seal machinery at its Kaysersberg site is now operational.
Nanologica AB has entered into a service agreement with CDMO Sterling Pharma Solutions for the large-scale production of silica particles.
March 16, 2018
The new 73,000-square-foot facility is one of several expansions to support the company’s biologics testing capabilities.
March 07, 2018
Grand River Aseptic Manufacturing announces first planned investment in capacity expansion.
In selling its contrast media business, Hovione will focus on API and drug product development and manufacturing.